SynthesisMedicine2017

Risk of rash associated with vandetanib treatment in non-small-cell lung cancer patients: A meta-analysis of 9 randomized controlled trials.

Yuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.